Evaluation of Liquorice Nanogel Versus Diode Laser as an Adjunctive Treatment for Patients With Periodontitis Stage Ⅲ.
Periodontology
1 other identifier
interventional
27
1 country
1
Brief Summary
Evaluation of the effect of liquorice nanogel versus diode laser on periodontitis stage Ⅲ clinically and microbiologically by molecular analysis of porphyromonas gingivalis using real time PCR.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Jul 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 28, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2026
CompletedFirst Submitted
Initial submission to the registry
May 12, 2026
CompletedFirst Posted
Study publicly available on registry
May 22, 2026
CompletedMay 22, 2026
May 1, 2026
1.2 years
May 12, 2026
May 19, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Quantitative analysis using real time pcr
3 months
Study Arms (3)
control group
EXPERIMENTALno drug was added to control group
Liquorice Nanogel
EXPERIMENTAL10% Liquorice was prepared in nanogel concentrate
Diode laser
EXPERIMENTALEpic X 0.9watt device was used
Interventions
Real Time pcr was chosen to detect 16s gene concentration for porphyromonas gingivalis bacteria that is specific for Periodontitis Stage 3.
Real time Pcr was used to detect gene concentration 16s specific for porphyromonas gingivalis
Eligibility Criteria
You may qualify if:
- Patient had Periodontitis stage III with pocket depth ≥ 6mm; indicated for periodontal surgery or CAL ≥ 5mm.
- Patient agreed to the surgical procedure and clinical trial.
- Age ranged between 18-50 years old.
You may not qualify if:
- : No previous drug was taken affecting bone metabolism. 2- Smoking. 3- Pregnant women and women with menopause. 4- Patients with psychological problems . 5- Patients with abnormal habits. 6- Patients with medical conditions as Diabetes or Hypertension.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Alazhar University for Girls
Cairo, Cairo Governorate, 00202, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Master Candidate of Oral and Dental Medicine and Periodontology Al Azhar University for girls
Study Record Dates
First Submitted
May 12, 2026
First Posted
May 22, 2026
Study Start
July 1, 2024
Primary Completion
September 28, 2025
Study Completion
April 1, 2026
Last Updated
May 22, 2026
Record last verified: 2026-05